Verity Watson

• Genetic
• Health Policy and Regulation
• Healthcare Expenditure
• Novartis
• Pricing and Reimbursement
• Systemic Conditions
• Cell and Gene Therapies

Exploring the Financial Sustainability of Gene Therapies

Read more

• ABPI
• Australia
• Canada
• Czech Republic
• HTA
• Ireland
• Japan
• Netherlands
• Norway
• Poland
• Scotland
• South Korea
• Sweden
• Taiwan
• Thailand
• UK
• US
• Health Technology Assessment…

International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making

Read more

• HTA
• Roche
• Health Technology Assessment…

Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?

Read more

• Clinical Outcomes

Managing Poorly Performing Clinicians: The Value of Independent Help

Read more